Last analyzed: May 28, 2026 (Q2 FY26)

Haleon plc

HLN

Pharmaceuticals

$9.21

Market Cap

$41M

P/E Ratio

18.48

Revenue Rank

Rank 4

Margin Rank

Rank 3

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks